Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.480.02%
QQQ
714.89-
BTC/USD
77296.590.1149%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Revolution Medicines Inc (RVMD) Stock Price, Quote, News & History

RVMDNASDAQ
Trade with Public
Trade with Public
$203.77
0.420.21%
At close: Sep 11, 5:00 PM EST
$203.77
N/A
After Hours: 4:33 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Revolution Medicines (RVMD) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$204.98
Close
$203.77
Volume / Avg.
1.38M / 2.26M
Day Range
$197.81 - $206.36
52 Wk Range
39.73 - 224.31
Market Cap
$43.68B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
4.79%
Days to Cover
4.69

Recent Revolution Medicines, Inc. News

Why Are 42% of US Cancer Patients Draining Their Life Savings in Two Years? Bernie Sanders Has a $400,000 Answer

Bernie Sanders blasts Big Pharma over $400,000 cancer drugs, warning soaring treatment costs can push patients into financial ruin.
Namrata Sen

SLS Stock Looks Like a $3 Billion Biotech Winner—This Short Seller Says the Market Has It Dangerously Wrong: 'Most Expensive Coin Flip' (UPDATED)

Short seller BMF Capital disclosed a short position in SELLAS Life Sciences, arguing the market has 'dangerously overvalued' the biotech.
Radhika Anilkumar Nadig

Snowflake To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BMO Capital cut the price
Avi Kapoor

When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges

SELLAS stock gains momentum following FDA approval for Revolution Medicines, highlighting SLS009 preclinical pancreatic cancer data.
Vandana Singh

Revolution Medicines Stock Trades Higher Following Landmark FDA Approval for Pancreatic Cancer Drug

Shares of Revolution Medicines are trading higher Thursday morning as a wave of Wall Street firms issued price target increases following the commercial rollout of the company's first-in-class oncology therapy.
Henry Khederian

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-1.58B
Investing Cash Flow (TTM)
-1.21B
Financing Cash Flow (TTM)
3.26B
Free Cash Flow (TTM)
-1.59B
Capital Expenditure (TTM)
-10.64M
Net Change in Cash (TTM)
471.13M

Analyst Trends and Forecast

6
1
May
6
Jun
6
Jul
15
1
Aug
2
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$40.33B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
16.74
Earnings Yield % (TTM)
-4.36%
Earnings Yield % (FWD)
-2.29%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$12.16

Company Debt

Total Debt
$487.43M
LT Debt
$487.43M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$815.44M
Debt to Equity
0.25
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$204.98
Close
$203.77
Volume / Avg.
1.38M / 2.26M
Day Range
$197.81 - $206.36
52 Wk Range
39.73 - 224.31
Market Cap
$43.68B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
4.79%
Days to Cover
4.69

About

Sector
Health Care
Industry
Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacolog...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Revolution Medicines (RVMD) stock?

A

You can purchase shares of Revolution Medicines (NASDAQ:RVMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Revolution Medicines (RVMD) competitors?

Q

What is the forecast, or price target, for Revolution Medicines (RVMD) stock?

A

Revolution Medicines has a consensus price target of $177.04.

Q

What is the current price for Revolution Medicines (RVMD)?

A

The stock price for Revolution Medicines (NASDAQ: RVMD) is $203.77 last updated September 11, 2026 at 4:33 PM EDT.

Q

Does Revolution Medicines (RVMD) pay a dividend?

A

There are no upcoming dividends for Revolution Medicines.

Q

When is Revolution Medicines (NASDAQ:RVMD) reporting earnings?

A

Revolution Medicines does not have any upcoming earnings scheduled.

Q

Is Revolution Medicines (RVMD) going to split?

A

There is no upcoming split for Revolution Medicines.

Q

What sector and industry does Revolution Medicines (RVMD) operate in?

A

Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved